HIV/AIDS
Pfizer Receives E.U. Approval of Maraviroc; Monogram Initiates European Operations
Published in AIDS Weekly, October 15th, 2007
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced the establishment of its European organization to facilitate access to Trofile, its proprietary tropism test, following the announcement that Pfizer Inc. (NYSE:PFE) has received European Commission approval of the novel HIV therapy, Celsentri(R) (maraviroc) tablets (known as Selzentry(TM) in the U.S.). Trofile was the assay used for patient selection for maraviroc's clinical development program and the two companies are engaged in a collaboration agreement to make Monogram's assay available for patient use globally.
Maraviroc has been approved in the European Union for combination antiretroviral therapy for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-10-15)
More Articles from AIDS Weekly
- HIV/AIDS
HIV-positive employees face job loss and workplace discrimination - HIV/AIDS Co-Infection
Drug Cocktail Stops Brain Damage Caused by HIV - DNA Vaccines
Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine - HIV/AIDS
AHF's Innovative 'Stay Negative' HIV Prevention Campaign Successfully Breaks Through to Target Audience - HIV/AIDS
amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach - HIV/AIDS
ASCP Receives Increase in Federal Funding for the Fight of AIDS in Africa - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
